Physician profile
Emanuele Orru'
NPI 1205244993
$24,285.12
in general payments reported to CMS, 2019-2025
9 companies · $2,926 in 2025
The $2,926 reported for 2025 was more than what 78% of Neuroradiology providers received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,207 · 2020: $95.99 · 2021: $689 · 2022: $14K · 2023: $2,998 · 2024: $2,335 · 2025: $2,926.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,189 · Food and Beverage: $3,070.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,188.68 |
| Food and Beverage | $3,070.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $20,247.03 | 2019-2025 | Surpass Evolve, Axs Vecta 71, Evolve |
| Medical Device Business Services, INC. | $1,376.61 | 2021-2025 | Cerepak Uniform |
| Penumbra, INC. | $1,017.16 | 2019-2025 | Penumbra System |
| Balt USA, LLC | $501.35 | 2021-2025 | Optima Coil System |
| Imperative Care, INC | $316.15 | 2023-2024 | Zoom 88-T Large Distal Platform |
| Depuy Synthes Sales INC. | $312.49 | 2021-2025 | Trufill, Embotrap, Cerepak Uniform |
| Viz.Ai, INC. | $197.63 | 2022 | |
| Microvention, INC. | $166.31 | 2025 | Tubing Kit - Stroke, Web Aneurysm Embolization System, Azur Cx Detachable |
| Route 92 Medical, INC. | $150.39 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emanuele Orru' listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.